Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (TSE:BHC)
NYSE:BHC
Total Valuation
Bausch Health Companies has a market cap or net worth of C$3.00B. The enterprise value is C$22.08B.
Market CapC$3.00B
Enterprise ValueC$22.08B
Share Statistics
Bausch Health Companies has 370,562,440 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding370,562,440
Owned by Insiders41.30%
Owned by Institutions41.37%
Financial Efficiency
Bausch Health Companies’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is 3.24%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)3.24%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee504.62K
Profits Per Employee7.72K
Employee Count20,700
Asset Turnover0.40
Inventory Turnover2.51
Valuation Ratios
The current PE Ratio of Bausch Health Companies is 14.5. Bausch Health Companies’s PEG ratio is -0.04.
PE Ratio14.5
PS Ratio0.25
PB Ratio-4.65
Price to Fair Value-4.65
Price to FCF2.64
Price to Operating Cash Flow1.57
PEG Ratio-0.04
Income Statement
In the last 12 months, Bausch Health Companies had revenue of 10.45B and earned 159.75M in profits. Earnings per share was 0.43.
Revenue10.45B
Gross Profit6.36B
Operating Income2.22B
Pretax Income373.42M
Net Income159.75M
EBITDA3.45B
Earnings Per Share (EPS)0.43
Cash Flow
In the last 12 months, operating cash flow was 1.40B and capital expenditures -408.39M, giving a free cash flow of 992.53M billion.
Operating Cash Flow1.40B
Free Cash Flow992.53M
Free Cash Flow per Share2.68
Dividends & Yields
Bausch Health Companies pays an annual dividend of C$0.097, resulting in a dividend yield of ―
Dividend Per ShareC$0.097
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.20
52-Week Price Change-22.14%
50-Day Moving Average9.00
200-Day Moving Average8.84
Relative Strength Index (RSI)46.70
Average Volume (3m)586.54K
Important Dates
Bausch Health Companies upcoming earnings date is Apr 30, 2026, Before Open (Confirmed).
Last Earnings DateFeb 18, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Bausch Health Companies as a current ratio of 1.47, with Debt / Equity ratio of -3835.02%
Current Ratio1.47
Quick Ratio1.08
Debt to Market Cap8.17
Net Debt to EBITDA5.76
Interest Coverage Ratio1.35
Taxes
In the past 12 months, Bausch Health Companies has paid 251.32M in taxes.
Income Tax251.32M
Effective Tax Rate0.67
Enterprise Valuation
Bausch Health Companies EV to EBITDA ratio is 6.51, with an EV/FCF ratio of 23.04.
EV to Sales2.15
EV to EBITDA6.51
EV to Free Cash Flow23.04
EV to Operating Cash Flow16.29
Balance Sheet
Bausch Health Companies has C$1.32B in cash and marketable securities with C$21.21B in debt, giving a net cash position of -C$19.88B billion.
Cash & Marketable SecuritiesC$1.32B
Total DebtC$21.21B
Net Cash-C$19.88B
Net Cash Per Share-C$53.66
Tangible Book Value Per Share-C$41.81
Margins
Gross margin is 68.33%, with operating margin of 21.28%, and net profit margin of 1.53%.
Gross Margin68.33%
Operating Margin21.28%
Pretax Margin3.57%
Net Profit Margin1.53%
EBITDA Margin33.05%
EBIT Margin21.28%
Analyst Forecast
The average price target for Bausch Health Companies is C$9.89, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetC$9.89
Price Target Upside22.28% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast8.68%
EPS Growth Forecast―